Marker system, in particular for baculovirus-expressed subunit antigens
AssigneeBoehringer Ingelheim Vetmedica GmbH
InventorsArun V. Iyer, Joseph Ralph Hermann, Michael B. Roof, Eric Martin Vaughn, Merrill Lynn Schaeffer
Life of this patent
Estimating the term…
Abstract
The present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a method of determining whether an individual has received an immunogenic composition comprising a recombinant protein produced by a baculovirus expression system in cultured insect cells.
Claims21
1-32. (canceled)
A method for determining whether an animal has received a marker vaccine including a recombinant protein produced by an expression system in cultured insect cells, comprising:
- detecting, in a biological sample derived from the animal, for a marker indicating whether the animal has been exposed to an antigen from an RNA virus capable of infecting insect cells.
Dependencies are inferred from the claim text.